Xperix Inc (317770) Fair Value & Analysis
Industrials · KR · Market cap 87.3B KRW
Fair value as of: Jul 9, 2026
From 1 valuation models · updated today
Fair value updated Jul 9, 2026 — revised from 7,331 KRW to 1,637 KRW (−77.7%) since Jun 24, 2026. Share price −10.6% over the past month.
Price vs Fair Value (12 months)
12‑month range 2,475 KRW – 4,801 KRW · fair‑value band 1,222 KRW – 2,444 KRW · the 2,475 KRW price screens above the 1,637 KRW fair value. As of Jul 9, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Xperix Inc (317770) currently trades at 2,475 KRW, while our model-based Fair Value estimate is 1,637 KRW — implying the stock looks roughly 33.8% overvalued today. We read business quality at 16/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Over the trailing twelve months, Xperix Inc generated revenue of 23.2B KRW at a net margin of -60.9%. Revenue grew 34.7% year over year. It earns a return on equity of -18.5%. Net debt stands at 8.3B KRW. Fundamentals as of Jul 9, 2026
Our scenario range runs from 1,222 KRW (bear case) to 2,444 KRW (bull case); at 2,475 KRW, the current price sits above that range. The share trades about 48% below its 52-week high and 1% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at -58% fair-value upside — at -34%, 317770 screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 9, 2026. TTM = trailing twelve months.
About the company
Xperix Inc. develops and provides end-to-end biometric identity solutions in South Korea and internationally. It offers authentication scanners and modules, enrollment scanners, document readers, and related software development kits. The company was formerly known as Suprema ID Inc. The company was founded in 2017 and is based in Seoul, South Korea.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Xperix Inc reported revenue of 21.5B KRW in FY2025 versus 14.5B KRW in FY2021, a compound +10.3%/yr. Reported net income was −19.5B KRW in FY2025.
Is 317770 fairly valued? → Check now
Similar stocks
10 more Building Products & Equipment stocks, each showing price versus our Fair Value estimate (as of Jul 9, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Trane Technologies plc TT | $456.84 | $192.91 | -58% |
| Johnson Controls International plc JCI | $143.65 | $28.67 | -80% |
| Carrier Global Corporation CARR | $71.85 | $17.22 | -76% |
| Compagnie de Saint-Gobain S.A CODGF | $89.95 | $106.78 | +19% |
| Daikin Industries,Ltd. DKILF | $149.65 | $113.38 | -24% |
| Geberit AG GBERF | $661.46 | $380.35 | -42% |
| Masco Corporation MAS | 1,559 MXN | 51.45 MXN | -97% |
| Kingspan Group KRX | €87.30 | €36.86 | -58% |
| Lennox International Inc LII | $536.04 | $297.27 | -45% |
| BELIMO Holding BLMOY | $11.78 | $3.43 | -71% |
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is Xperix Inc (317770) undervalued?
What is the fair value of 317770?
What is the quality score of 317770?
What is the revenue of Xperix Inc (317770)?
What is the net profit margin of 317770?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.